Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 167976, 4 pages
http://dx.doi.org/10.1155/2015/167976
Research Article

A Potential Epigenetic Marker Mediating Serum Folate and Vitamin B12 Levels Contributes to the Risk of Ischemic Stroke

1Centre for Biodiversity Research, Universiti Tunku Abdul Rahman, Bandar Barat, 31900 Kampar, Perak, Malaysia
2Department of Biological Science, Faculty of Science, Universiti Tunku Abdul Rahman, Bandar Barat, 31900 Kampar, Perak, Malaysia
3Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology, Musk Avenue, Kelvin Grove, QLD 4059, Australia
4Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

Received 6 October 2014; Accepted 27 December 2014

Academic Editor: Gelin Xu

Copyright © 2015 Loo Keat Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Matouk, P. J. Turgeon, and P. A. Marsden, “Epigenetics and stroke risk—beyond the static DNA code,” Advances in Genomics and Genetics, vol. 2, pp. 67–84, 2012. View at Publisher · View at Google Scholar
  2. A. Baccarelli, R. Wright, V. Bollati et al., “Ischemic heart disease and stroke in relation to blood DNA methylation,” Epidemiology, vol. 21, no. 6, pp. 819–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Batra and T. P. A. Devasagayam, “Interaction between γ-radiation and dietary folate starvation metabolically reprograms global hepatic histone H3 methylation at lysine 4 and lysine 27 residues,” Food and Chemical Toxicology, vol. 50, no. 3-4, pp. 464–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. I. A. Qureshi and M. F. Mehler, “Emerging role of epigenetics in stroke. Part 1. DNA methylation and chromatin modifications,” Archives of Neurology, vol. 67, no. 11, pp. 1316–1322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Freson, B. Izzi, and C. van Geet, “From genetics to epigenetics in platelet research,” Thrombosis Research, vol. 129, no. 3, pp. 325–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-A. Lee, S.-H. Hong, J.-W. Kim, and I.-S. Jang, “Possible involvement of DNA methylation in NKCC1 gene expression during postnatal development and in response to ischemia,” Journal of Neurochemistry, vol. 114, no. 2, pp. 520–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Castro, I. Rivera, P. Ravasco et al., “5,10-Methylenetetrahydrofolate reductase (MTHFR) 677CT and 1298AC mutations are associated with DNA hypomethylation,” Journal of Medical Genetics, vol. 41, no. 6, pp. 454–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Soriano-Tárraga, J. Jiménez-Conde, E. Giralt-Steinhauer et al., “Global DNA methylation of ischemic stroke subtypes,” PLoS ONE, vol. 9, no. 4, Article ID e96543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fernàndez-Roig, S.-C. Lai, M. M. Murphy, J. Fernandez-Ballart, and E. V. Quadros, “Vitamin B12 deficiency in the brain leads to DNA hypomethylation in the TCblR/CD320 knockout mouse,” Nutrition & Metabolism, vol. 9, article 41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Wei, S. Heidi, C. Emily, M. H. Larisa, R. G. Lyn, and H. G. Siew, “Computational epigenetic profiling of CpG islets in MTHFR,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  11. S. Majocchi, E. Aritonovska, and N. Mermod, “Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes,” Nucleic Acids Research, vol. 42, no. 1, pp. 193–204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Vineis, S. C. Chuang, T. Vaissière et al., “DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study,” Epigenetics, vol. 6, no. 2, pp. 195–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Alonso-Aperte, M. P. González, R. Póo-Prieto, and G. Varela-Moreiras, “Folate status and S-adenosylmethionine/S-adenosylhomocysteine ratio in colorectal adenocarcinoma in humans,” European Journal of Clinical Nutrition, vol. 62, no. 2, pp. 295–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Pezzini, E. Del Zotto, and A. Padovani, “Homocysteine and cerebral ischemia: pathogenic and therapeutical implications,” Current Medicinal Chemistry, vol. 14, no. 3, pp. 249–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. N. U. Okubadejo, O. O. Oladipo, A. A. Adeyomoye, G. O. Awosanya, and M. A. Danesi, “Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians,” BMC Neurology, vol. 8, article 26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ghattas, F. El-Shaarawy, N. Mesbah, and D. Abo-Elmatty, “DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients,” Molecular Biology Reports, vol. 41, no. 2, pp. 683–688, 2014. View at Publisher · View at Google Scholar · View at Scopus